by Amy Wilding-Fox
The latest Kansas bill fell short yet again in its attempt to legalize cannabis medicinally for the state. Instead, new legislation was signed by the governor that will grant access to only FDA approved medicinal marijuana. That includes the CBD oil Edioplex that has been heavily criticized for its expensive costs. There are also three synthetic “cannabis-related” products that have gotten the green light from the FDA for nausea that will soon be available for HIV, Cancer, and AIDS patients. As the FDA continues to expand its research on cannabis, Kansas may eventually receive more products as they become approved down the line.
In response to the change, Senate President Ty Masterson, R-Andover, told reporters in that it was uncertain any of the proposals to date would have been able to get a majority of votes needed for passage in his chamber anyway. “I think the subject matter is mature and you will see it next year," Masterson said.
In a statement after the Legislature adjourned for the year, Sen. Rob Olson, R-Olathe, chair of the Senate Federal and State Affairs Committee, said that "I regret and take responsibility" for the policy not passing his chamber. He went on to say that key issues still need to be addressed and resolved next year, as well.
View this article on our website.
